arrow
F

Ferdia A. Gallagher

University of Cambridge
H指数:50
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Estimating the Sodium Content: A Case Series of Benign and Malignant Renal Tumours Using 23Na-MRI at 3 T

利用3T 23Na-MRI评估良性及恶性肾肿瘤的钠含量:病例系列研究

2026-06-240
OAAI
Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1-13 C]pyruvate MRI

评估透明细胞肾细胞癌新辅助治疗的代谢效应:采用高极化[1-13 C]丙酮酸MRI

2025-12-010
OAAI
Early Detection of Chemotherapy-Induced Glucose Metabolic Alterations in Bladder Carcinoma Using Deuterium (2H) Metabolic Imaging: in Vitro and in Vivo Assessments

使用氘(2H)代谢成像对膀胱癌化疗诱导的糖代谢改变进行早期检测:体外与体内评估

2025-11-140
OAAI
In vivo gastrin releasing peptide receptor expression in SDH deficient wild-type gastrointestinal stromal tumours (GIST): potential for theranostic applications

体内胃泌素释放肽受体在SDH缺乏的野生型胃肠道间质瘤(GIST)中的表达:在治疗诊断应用中的潜力

2025-10-210
OA
Investigating the mechanisms of neoadjuvant olaparib and cediranib in renal cancer: results of arms 1 to 3 of the WIndow of opportunity in REnal cancer (WIRE) clinical trial

探究新辅助奥拉帕利和西地尼布在肾癌中的作用机制:WIndow of opportunity in REnal cancer (WIRE) 临床试验第1至3组的试验结果

2025-10-010
OAAI
Angiogenic and immune predictors of neoadjuvant axitinib response in renal cell carcinoma with venous tumour thrombus

肾细胞癌静脉肿瘤血栓中轴突生的血管生成和免疫预测因子对新辅助阿昔替尼治疗反应的预测

2025-04-280
OA
Quantifying the tumour vasculature environment from CD-31 immunohistochemistry images of breast cancer using deep learning based semantic segmentation

使用基于深度学习的语义分割从乳腺癌的CD-31免疫组织化学图像量化肿瘤脉管系统环境

2025-02-040
OAAI
Metabolic imaging across scales reveals distinct prostate cancer phenotypes
2024-07-160
OAAI
Fast and High-Resolution T2 Mapping Based on Echo Merging Plus k-t Undersampling with Reduced Refocusing Flip Angles (TEMPURA) as Methods for Human Renal MRI

基于回波合并的快速高分辨率T2映射加上具有减少的重聚焦翻转角 (天妇罗) 的k-t欠采样作为人类肾脏MRI的方法

2024-05-102
OA
New Horizons in Hyperpolarized 13C MRI

超极化13C MRI的新视野

2023-12-2611
OAAI